A minimal-invasive method for systemic bio-monitoring of the environmental pollutant phenanthrene in humans: Thermal extraction and gas chromatography - mass spectrometry from 1 mL capillary blood.

Phenanthrene is present in numerous environmental media and serves as a model substrate for the biomonitoring of polycyclic aromatic hydrocarbon (PAH). PAH exposure studies are commonly focused on urinary metabolites, concentrations of which are dependent on absorption, biotransformation and excretion. Monitoring of unmetabolized PAHs in blood would allow more reliable exposure assessment, but requires invasive sampling and extensive sample preparation. We describe the analysis of phenanthrene in 1µL capillary blood using thermal extraction (TE) combined with gas chromatography - mass spectrometry (GC-MS). Less invasive sampling of 1µL capillary blood does not require the assistance of medical staff. Compared to previous studies, analysis time was improved significantly by TE due to minimization of sample preparation steps. The evaluate method was applied successfully to the monitoring of phenanthrene blood levels. This is the first report presenting the pharmacokinetics of unmetabolized PAHs in human.

A mouse model for ulcerative colitis based on NOD-scid IL2R γnull mice reconstituted with peripheral blood mononuclear cells from affected individuals.

Animal models reflective of ulcerative colitis (UC) remain a major challenge, and yet are crucial to understand mechanisms underlying the onset of disease and inflammatory characteristics of relapses and remission. Mouse models in which colitis-like symptoms are induced through challenge with toxins such as oxazolone, dextran sodium sulfate (DSS) or 2,4,6-trinitrobenzenesulfonic acid (TNBS) have been instrumental in understanding the inflammatory processes of UC. However, these neither reflect the heterogeneous symptoms observed in the UC-affected population nor can they be used to test the efficacy of inhibitors developed against human targets where high sequence and structural similarity of the respective ligands is lacking. In an attempt to overcome these problems, we have developed a mouse model that relies on NOD-scid IL2R γ(null) mice reconstituted with peripheral blood mononuclear cells derived from UC-affected individuals. Upon challenge with ethanol, mice developed colitis-like symptoms and changes in the colon architecture, characterized by influx of inflammatory cells, edema, crypt loss, crypt abscesses and epithelial hyperplasia, as previously observed in immune-competent mice. TARC, TGFß1 and HGF expression increased in distal parts of the colon. Analysis of human leucocytes isolated from mouse spleen revealed an increase in frequencies of CD1a+, CD64+, CD163+ and TSLPR+ CD14+ monocytes, and antigen-experienced CD44+ CD4+ and CD8+ T-cells in response to ethanol. Analysis of human leucocytes from the colon of challenged mice identified CD14+ monocytes and CD11b+ monocytes as the predominant populations. Quantitative real-time PCR (RT-PCR) analysis from distal parts of the colon indicated that IFNγ might be one of the cytokines driving inflammation. Treatment with infliximab ameliorated symptoms and pathological manifestations, whereas pitrakinra had no therapeutic benefit. Thus, this model is partially reflective of the human disease and might help to increase the translation of animal and clinical studies.